AI for Life Sciences

We partner with companies in medical devices and biotechnology, as well as academia and government institutions, to develop breakthrough products and enable new scientific discoveries.



Artificial Intelligence for Cellular and Tissue Analysis

PhenoLearn lets scientists create and deploy highly accurate and robust models of cellular and tissue phenotypes using artificial intelligence.

Visit PhenoLearn


Contractility Analysis of Cardiomyocyte Videos

The Pulse web service lets scientists upload their own videos of beating cardiomyocytes for automated analysis of contractility.

Visit Pulse


Artificial Intelligence for In Vitro Structural Toxicity Testing

PhenoTox uses artificial intelligence to capture drug-induced structural changes in images of cell cultures.

Coming Soon

Consulting Services

Novel Algorithms

We develop novel algorithms for analyzing biomedical images, videos, and sensor data, tailored to your project requirements.

Product Ready

We develop end-to-end solutions, deployed in your favorite local or cloud-based environment.

Made with Passion

We work as an extended part of your team, and treat every project as if it were one of our own.

Featured Clients

Genea Biomedx

Tenaya Therapeutics

Gladstone Institutes


Advanced Reproductive Care ARC

Fountain Therapeutics

Stanford Bioengineering

Enspectra Health

News & Events


Dana Solutions to present and exhibit at SPS 2019 Annual Meeting

Come visit us at booth #702, and see our poster titled "Artificial Intelligence Method Enables Evaluation of Both Acute and Chronic Drug Effects."


Dana Solutions to present at 2019 ISSCR Annual Meeting

Come see our poster T-3222 titled "Artificial Intelligence Captures Structural Toxicity in Human In Vitro Cell Models on Thursday June 27 at 7pm in Poster Session II Even.


Dana Solutions to present and exhibit at 2019 SOT Annual Meeting and ToxExpo

Come visit us at booth #2312, and see our poster P365 titled "A Novel Tool For Structural Toxicity Testing With In Vitro Models" on Thursday March 14 from 8:30am to 11:30am.


FDA signs collaborative agreement with Dana Solutions to apply deep-learning algorithms for drug safety testing

Dana Solutions announced today that it has entered into a Research Collaboration Agreement with the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research.


Dana Solutions presents at the Gladstone Institutes MicroBites Seminar

We were invited to present to researchers at the Gladstone Institutes, and talk about how PhenoLearn can be used for image-based phenotypic modeling, drug screening, quality control, and more.

Managing Members

Kevin Loewke, PhD

Mahnaz Maddah, PhD

Contact Us

3505 El Camino Real
Palo Alto, CA 94306